EUVIMEDEUVIMED entdecken
Crossref

STC-1 alleviates airway inflammation by regulating epithelial cell apoptosis through the 5-LO pathway

Shijia Wang, Zhijian Tu, Chenping Li, Xiao Jin, Zehong Chen, Xiaofei Ye, Shuyao Xu, Jihao Cai, Chang Cai

Inflammation · 2024

DOI: 10.1007/s10753-024-02181-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammation, 2024. Verfasst von Shijia Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China. Hauptthemen laut MEDLINE: Apoptosis, Epithelial Cells, Asthma, Glycoproteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Airway inflammation plays a key role in the pathogenesis and development of asthma. Stanniocalcin-1 (STC-1) has powerful antioxidant, anti-inflammatory and anti-apoptotic functions but its impact on the airway inflammation in asthma lacks evidence. Here, we investigated the effect and potential mechanism of STC-1 on airway inflammation through asthmatic mice model and lipopolysaccharide (LPS)-treated BEAS-2B cells. The data showed that STC-1 treatment before the challenge exerted protective effect on ovalbumin (OVA)-induced asthmatic mice, i.e., decreased the inflammatory cell infiltration, mucus secretion, cytokine levels, apoptosis levels, and p38 MAPK signaling. Additionally, STC-1 reduced 5-LO expression. Meanwhile, STC-1 decreased p38 MAPK signaling, cytokine production, mucin MUC5AC production, 5-LO expression and nuclear translocation, and LTB4 production in vitro. Ultimately, transforming growth factor β (TGF- β ), as a 5-LO inducer, reversed the anti-inflammatory and anti-apoptotic effects of STC-1 in BEAS-2B cells by up-regulating 5-LO expression. It reveals the potential of STC-1 to act as an additional therapy to mitigate airway inflammation in asthma and inhibit 5-LO expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisEpithelial CellsAsthmaGlycoproteinsAnimalsMiceInflammationHumansSignal TransductionCell LineMice, Inbred BALB COvalbuminLipopolysaccharides

Stichwörter der Autor:innen

Airway inflammationApoptosisAsthmaStanniocalcin-1

Substanzen

teleocalcinGlycoproteinsOvalbuminLipopolysaccharides

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China.
  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Renji College of Wenzhou Medical University, Wenzhou, China.
  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. WZFY2017@163.com.
  • To whom correspondence should be addressed at Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. WZFY2017@163.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, S., Tu, Z., Li, C., Jin, X., Chen, Z., Ye, X., Xu, S., Cai, J., & Cai, C. (2024). STC-1 alleviates airway inflammation by regulating epithelial cell apoptosis through the 5-LO pathway. Inflammation. https://doi.org/10.1007/s10753-024-02181-5

Vancouver

Wang S, Tu Z, Li C, Jin X, Chen Z, Ye X, et al. STC-1 alleviates airway inflammation by regulating epithelial cell apoptosis through the 5-LO pathway. Inflammation. 2024. doi:10.1007/s10753-024-02181-5

BibTeX
@article{Wang2024,
  author = {Wang, Shijia and Tu, Zhijian and Li, Chenping and Jin, Xiao and Chen, Zehong and Ye, Xiaofei and Xu, Shuyao and Cai, Jihao and Cai, Chang},
  title = {STC-1 alleviates airway inflammation by regulating epithelial cell apoptosis through the 5-LO pathway},
  journal = {Inflammation},
  year = {2024},
  doi = {10.1007/s10753-024-02181-5}
}
Kostenlos starten →